No. | Accession No. | Gene Symbol | Gene Name | Fold change | p-value |
---|---|---|---|---|---|
Apoptosis | Â | Â | Â | Â | |
Induction of apoptosis | Â | Â | Â | Â | |
1 | NM_138765.2 | BAX | BCL2-associated X protein, transcript variant sigma | -4.19 | 0.0062 |
2 | NM_004324.3 | BAX1 | BCL2-associated X protein, transcript variant beta | -4.67 | 0.0059 |
3 | NM_001225.3 | CASP4 | Caspase 4, transcript variant alpha | -2.32 | 0.0027 |
4 | NM_001226.3 | CASP61 | Caspase 6, transcript variant alpha | 3.17 | 0.0401 |
5 | NM_021202.1 | TP53INP2 | Tumor protein p53 inducible nuclear protein 2 | -3.02 | 0.0034 |
6 | NM_147184.1 | TP53I3/PIG3 | Tumor protein p53 inducible protein 3, transcript variant 2 | -3.67 | 0.0031 |
Inhibition of apoptosis | Â | Â | Â | Â | |
7 | NM_138578.1 | BCL2L11 | B-cell CLL/lymphoma 2-like 1, transcript variant 1 | -2.95 | 0.0124 |
8 | NM_003840.3 | TNFRSF10D1 | Tumor necrosis factor receptor superfamily, member 10d | -33.80 | 0.0005 |
Cell cycle, proliferation and differentiation | Â | Â | |||
9 | NM_001012271.1 | BIRC5 | Baculoviral IAP repeat-containing 5 (Survivin), transcript variant 3 | 4.60 | 0.0024 |
 |  | BIRC5 |  | 12.61 | 1.8E-05 |
10 | NM_031966.2 | CCNB1 | Cyclin B1 | 18.17 | 0.0005 |
11 | NM_001759.2 | CCND21 | Cyclin D2 | -75.73 | 0.0427 |
12 | NM_001238.1 | CCNE11 | Cyclin E1, transcript variant 1 | 2.34 | 0.0310 |
13 | NM_057735.1 | CCNE2 | Cyclin E2, transcript variant 2 | 9.33 | 0.0198 |
14 | NM_001786.2 | CDC2/CDK1 | Cell division cycle 2, transcript variant 1 | 6.32 | 0.0127 |
15 | NM_001790.3 | CDC25C | Cell division cycle 25 homolog C, transcript variant 1 | 17.05 | 0.0020 |
16 | NM_001790.3 | CDC25C | Cell division cycle 25 homolog C, transcript variant 1 | 15.26 | 0.0001 |
17 | NM_022809.2 | CDC25C | Cell division cycle 25 homolog C, transcript variant 2 | 13.39 | 0.0011 |
 |  | CDC25C |  | 18.21 | 0.0004 |
18 | NM_058197.3 | CDKN2A1 | Cyclin-dependent kinase inhibitor 2A, transcript variant 3 | 3.14 | 0.0472 |
 |  | CDKN2A |  | 1.56 | 0.4706 |
19 | NM_001274.3 | CHEK1 | CHK1 checkpoint homolog | 3.14 | 0.0105 |
20 | NM_016426.4 | GTSE1 | G-2 and S-phase expressed 1 | 6.69 | 0.0014 |
21 | NM_182649.1 | PCNA1 | Proliferating cell nuclear antigen, transcript variant 2 | 4.66 | 0.0397 |
22 | NM_006034.2 | TP53I11 | Tumor protein p53 inducible protein 11 | -54.31 | 2.31E-06 |
DNA repair | Â | Â | Â | Â | |
23 | NM_007304.2 | BRCA1 | Breast cancer 1, transcript variant BRCA1-delta11b | 3.70 | 0.0092 |
24 | NM_007299.2 | BRCA1 | Breast cancer 1, transcript variant BRCA1-delta14-17 | 3.06 | 0.0068 |
 |  | BRCA1 |  | 5.47 | 0.0037 |
Immunity and defense | Â | Â | Â | Â | |
25 | NM_000963.1 | PTGS2 | Prostaglandin-endoperoxide synthase 2 | -15.59 | 0.0074 |
Metabolism | Â | Â | Â | Â | |
26 | NM_201397.1 | GPX1 | Glutathione peroxidase 1, transcript variant 2 | -2.16 | 0.0011 |
27 | NM_004530.2 | MMP2 | Metallopeptidase 2 | -6.61 | 0.0296 |
28 | NM_001034.1 | RRM21 | Ribonucleotide reductase M2 polypeptide | 10.48 | 0.0068 |
Signal Transduction | Â | Â | Â | Â | |
29 | NM_000623.2 | BDKRB2 | Bradykinin receptor B2 | -16.54 | 0.0040 |
Transport | Â | Â | Â | Â | |
30 | NM_002539.1 | ODC1 | Ornithine decarboxylase 1 | 4.12 | 0.0099 |
31 | NM_018976.3 | SLC38A2 | Solute carrier family 38, member 2 | -5.03 | 0.0074 |
Biological function unclassified | Â | Â | Â | ||
32 | NM_018685.2 | ANLN | Anillin | 8.88 | 4.17E-06 |
33 | XM_001133677.1 | LOC729264 | PREDICTED: Similar to TP53TG3 protein, transcript variant 2 | 25.41 | 0.0068 |
34 | NM_016212.2 | TP53TG3 | Tumor protein p53 target gene 3 | 102.59 | 0.0005 |